Medicare Advantage members whose plans will not return in 2027 begin receiving non-renewal notices this September, and the most expensive mistake is treating that letter as junk mail. Doing nothing does not preserve the old plan or roll a member into a comparable one. It drops the person back into Original Medicare on January 1, stripped of the prescription coverage, the out-of-pocket ceiling, and the extra benefits the Advantage plan bundled together. The default that arrives by inaction is not a safety net. It is a gap that has to be closed on purpose.
The letter that arrives in September
Insurers are ending Advantage plans that cover hundreds of thousands of members in 2027, with formal non-renewal notices scheduled to reach households beginning in September, according to reporting on the coming plan exits. A non-renewal is not a premium increase or a trimmed benefit. The plan simply will not exist in the member’s county next year. The notice, sometimes labeled a plan termination letter or folded into the Annual Notice of Change, is the only formal warning most members receive that their coverage has an expiration date.
The letter matters because Medicare treats silence as a decision. A member who reads the notice, sets it aside, and takes no further step is not automatically matched to a similar plan or kept on the old one. Coverage lapses at year-end, and the person reverts to Original Medicare on January 1 under Medicare’s rules for when a plan leaves the program. That fallback is where the trouble starts, because Original Medicare is a narrower product than the plan being lost.
Free retirement updates: Social Security and Medicare change every year, and nobody sends you a memo. Our free Retirement Shield newsletter breaks down what changed and what to do. Get it free in your inbox.
Original Medicare arrives without Part D
Original Medicare covers hospital and physician services but does not include outpatient prescription drugs, which live in Part D or inside an Advantage plan. A member dropped back to Parts A and B therefore lands with no drug coverage at all unless they separately enroll in a standalone Part D plan. For someone taking brand-name medications, the difference between a bundled Advantage drug benefit and no coverage can run into thousands of dollars over a single year.
The exposure is uneven. A member who takes only low-cost generics may absorb the gap with little pain, while a member on insulin, blood thinners, or a specialty medication faces the full retail price the day coverage lapses. Because Advantage plans fold the drug benefit into one card, many members do not realize the drug coverage is a separate product that disappears with the plan, and only discover the gap when a pharmacy declines to fill a January prescription at the old price.
Enrolling in Part D is not automatic either. It requires choosing a plan during an enrollment window, and a break in creditable drug coverage can trigger a permanent late-enrollment penalty added to future premiums. That surcharge compounds for every month spent without coverage, so the cost of ignoring the letter is not only the immediate gap but a charge that can follow the member for as long as they hold a drug plan.
The spending cap and Medigap safety net do not carry over
Advantage plans include an annual out-of-pocket maximum that limits what a member pays for covered care. Original Medicare has no such ceiling: Part B generally pays 80 percent of covered costs and leaves the remaining share open-ended. A retiree who returns to Original Medicare without a supplement is exposed to unlimited cost-sharing on a serious illness, which is the precise risk the Advantage cap was built to contain.
The usual remedy is a Medigap policy, but the guaranteed right to buy one without medical underwriting is time-limited. Outside a protected window, insurers in most states may screen applicants for health and decline coverage or charge more. A member who waits too long after the plan exit can find that the supplement that would have capped their exposure is no longer available on guaranteed terms, converting a temporary transition into a lasting cost.
Timing is what turns a manageable transition into a trap. The involuntary loss of an Advantage plan does open special windows to pick up new drug and supplement coverage, but those windows have edges and do not all run the same length. A member who treats the September letter as merely informational, and waits until a prescription is denied at the January counter to act, may already be past the cleanest path back. The options do not vanish overnight, but each week of delay narrows them, and the protections that were automatic inside the window become harder to reclaim once it has closed.
The non-renewal letter, then, is not a notice that something will be handled. It is the start of a clock. A member who acts turns an involuntary plan loss into a routine switch; a member who ignores it inherits a version of Medicare with no drug plan, no spending cap, and a narrowing path back to the supplement that would restore one. The letter looks like paperwork, but the silence after it is the decision that costs the most.
This article was researched and drafted with the assistance of AI and reviewed by The Money Overview editorial team.
More Financial Reading
